Starting April 1, CVS Health will no longer offer AbbVie’s Humira to most of the millions of patients in its commercial prescription plans. — Reuters
NEW YORK: The biggest US drug-benefits manager is making a move that will take a bite out of sales for one of the world’s top-selling medications.
Starting April 1, CVS Health Corp will no longer offer AbbVie Inc’s Humira to most of the millions of patients in its commercial prescription plans.
